Japan, Oct. 5 -- REGENERON PHARMACEUTICALS INC has got intellectual property rights for 'ANTI-LAG3 ANTIBODIES AND USES THEREOF.' Other related details are as follows:
Application Number: JP,2025-016024
Category (FI): C12N5/10,C07K16/28,C12N15/13,A61K39/395@T,A61K39/395@U,A61K39/395@S,A61K31/58,A61K31/573,A61P31/18,A61P31/14,A61P31/20,A61K39/395@N,C12P21/08,A61K45/00,A61P35/00,C12N15/63@Z,C12N1/15,C12N1/19,C12N1/21
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 3, 2025
Publication Date: April 30, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
